Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Credit agrmnt [a]
|
|
WEST PHARMACEUTICAL SERVICES INC (WST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Reiss-Clark Cindy (Chief Commercial Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 3,477 shares
@ $393.34, valued at
$1.4M
Exercised 777 options to buy
@ $369.13, valued at
$286.8k
Exercised 1,588 options to buy
@ $274.29, valued at
$435.6k
Exercised 1,112 options to buy
@ $173.22, valued at
$192.6k
|
|
| 08/15/2023 |
4
| Lai Quintin J (VP Strat & Investor Relations) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 10,725 shares
@ $394.6225, valued at
$4.2M
Sold 8,635 shares
@ $395.5426, valued at
$3.4M
Sold 1,741 shares
@ $396.123, valued at
$689.7k
Exercised 8,772 options to buy
@ $89.64, valued at
$786.3k
Exercised 7,140 options to buy
@ $102.51, valued at
$731.9k
Exercised 3,348 options to buy
@ $173.22, valued at
$579.9k
Exercised 1,388 options to buy
@ $274.29, valued at
$380.7k
Exercised 453 options to buy
@ $369.13, valued at
$167.2k
|
|
| 08/11/2023 |
4
| Witherspoon Charles (VP & Treasurer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 1,680 shares
@ $396.54, valued at
$666.2k
Exercised 840 options to buy
@ $173.22, valued at
$145.5k
Exercised 840 options to buy
@ $102.51, valued at
$86.1k
|
|
| 08/10/2023 |
4
| Abraham Silji (SVP, Chief Technology Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 8,154 shares
@ $397.1776, valued at
$3.2M
Sold 6 shares
@ $397.69, valued at
$2.4k
Exercised 8,160 options to buy
@ $102.51, valued at
$836.5k
|
|
| 08/10/2023 |
4
| Green Eric Mark (President & CEO) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 1,000 shares
@ $389.62, valued at
$389.6k
Sold 4,500 shares
@ $392.1553, valued at
$1.8M
Sold 7,055 shares
@ $393.131, valued at
$2.8M
Sold 8,329 shares
@ $394.174, valued at
$3.3M
Sold 7,684 shares
@ $395.0733, valued at
$3M
Sold 6,700 shares
@ $396.1253, valued at
$2.7M
Sold 7,532 shares
@ $397.1762, valued at
$3M
Sold 1,100 shares
@ $397.8964, valued at
$437.7k
Sold 100 shares
@ $398.87, valued at
$39.9k
Exercised 50,000 options to buy
@ $57.38, valued at
$2.9M
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
4
| Birkett Bernard (Sr VP, Chief Fin & Ops Off) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 22,134 shares
@ $370.3809, valued at
$8.2M
Sold 200 shares
@ $371.025, valued at
$74.2k
Exercised 8,450 options to buy
@ $102.51, valued at
$866.2k
Exercised 13,884 options to buy
@ $100.92, valued at
$1.4M
|
|
| 07/27/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/27/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 06/28/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 06/28/2023 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
| 05/31/2023 |
4
| Witherspoon Charles (VP & Treasurer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 1,000 shares
@ $343.05, valued at
$343.1k
Exercised 1,000 options to buy
@ $102.51, valued at
$102.5k
|
|
| 05/31/2023 |
4
| Winters Chad (VP, Chief Accounting Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Exercised 872 shares
@ $339.51, valued at
$296.1k
Exercised 872 options to buy
@ $143.43, valued at
$125.1k
|
|
| 05/25/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/11/2023 |
4
| Green Eric Mark (President & CEO) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 14,157 shares
@ $361.9468, valued at
$5.1M
Sold 12,562 shares
@ $362.9267, valued at
$4.6M
Sold 12,648 shares
@ $363.9354, valued at
$4.6M
Sold 4,133 shares
@ $364.7645, valued at
$1.5M
Sold 500 shares
@ $365.458, valued at
$182.7k
Exercised 50,000 options to buy
@ $57.38, valued at
$2.9M
|
|
| 05/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
4
| Winters Chad (VP, Chief Accounting Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Paid exercise price by delivering 10 shares
@ $368.46, valued at
$3.7k
|
|
| 05/02/2023 |
4
| Hofmann Thomas W (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 1,212 shares
@ $365.575, valued at
$443.1k
|
|
| 05/02/2023 |
4
| Abraham Silji (SVP, Chief Technology Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 7,371 shares
@ $365.5532, valued at
$2.7M
Sold 649 shares
@ $366.1385, valued at
$237.6k
Exercised 8,020 options to buy
@ $86.24, valued at
$691.6k
|
|
| 05/02/2023 |
4
| Favorite Annette F (Sr. VP & Chief HR Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Sold 9,425 shares
@ $365.4683, valued at
$3.4M
Sold 2,687 shares
@ $366.4632, valued at
$984.7k
Sold 900 shares
@ $367.4527, valued at
$330.7k
Exercised 13,012 options to buy
@ $59.64, valued at
$776k
|
|
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| FRIEL ROBERT F (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 616 shares
@ $0 |
|
| 04/27/2023 |
4
| Pucci Paolo (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 616 shares
@ $0 |
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Joseph Molly (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 616 shares
@ $0 |
|
| 04/27/2023 |
4
| Keller Deborah L (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC|
Txns:
| Granted 616 shares
@ $0 |
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/27/2023 |
8-K
| Quarterly results |
| 03/28/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
|
|
|